| Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015) A Singh, A Singh, D Sen Stem cell research & therapy 7, 1-25, 2016 | 246 | 2016 |
| Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo K Albert, DP Raymundo, A Panhelainen, A Eesmaa, L Shvachiy, ... Molecular Therapy 29 (9), 2821-2840, 2021 | 41 | 2021 |
| Therapeutic Value of Adeno Associated Virus as a Gene Therapy Vector for Parkinson's Disease–A Focused Review A Singh, D Sen Current Gene Therapy 16 (4), 278-286, 2016 | 11 | 2016 |
| Combining fibril‐induced alpha‐synuclein aggregation and 6‐hydroxydopamine in a mouse model of Parkinson's disease and the effect of cerebral dopamine neurotrophic factor on … A Singh, A Panhelainen, S Reunanen, KC Luk, MH Voutilainen European Journal of Neuroscience 59 (1), 132-153, 2024 | 2 | 2024 |
| OPTIMIZATION OF ALPHA-SYNUCLEIN-BASED MODELS OF PARKINSON’S DISEASE AND EFFECT OF CDNF ON NEURONAL DAMAGE A Singh Helsingin yliopisto, 2024 | | 2024 |
| Feasibility of combining alpha-synuclein aggregation and 6-OHDA in embryonic midbrain culture for modeling dopamine neuron degeneration A Singh, A Panhelainen, MH Voutilainen Neuroscience Letters, 137510, 2023 | | 2023 |
| Effect of CDNF in a novel combination stressor model of Parkinson's disease A Singh, A Panhelainen, M Voutilainen MOVEMENT DISORDERS 37, S473-S473, 2022 | | 2022 |
| Characterization of novel alpha-synuclein aggregation model of Parkinson's disease A Singh, S Reunanen, A Panhelainen, M Voutilainen MOVEMENT DISORDERS 35, S483-S483, 2020 | | 2020 |
Abhishek SinghUniversity of OuluVerified email at oulu.fi